Is Progressive Osseous Heteroplasia hereditary?

Progressive Osseous Heteroplasia (POH) is a genetic condition caused by mutations in the GNAS gene, and it is inherited in an autosomal dominant manner. While it is hereditary, many cases of Progressive Osseous Heteroplasia arise from de novo (spontaneous) mutations, meaning the individual is the first in their family to be affected.

Is Progressive Osseous Heteroplasia hereditary?

Progressive Osseous Heteroplasia is a rare genetic disorder characterized by the abnormal formation of bone within skin, muscle, and other soft tissues. Because it is caused by mutations in the GNAS gene, it is considered a genetic condition. It follows an autosomal dominant inheritance pattern, meaning an affected parent has a 50% chance of passing the mutation to each child. However, because many cases of Progressive Osseous Heteroplasia occur as de novo mutations during early embryonic development, there is often no prior family history of the disorder.

What is the role of genetic testing and counseling?

Genetic testing for Progressive Osseous Heteroplasia involves sequencing the GNAS gene to identify pathogenic variants. Clinical geneticists recommend testing when clinical symptoms—such as dermal ossification followed by deep tissue ossification—are present. Genetic counseling is essential for families to understand the risks of recurrence and to discuss family planning options. Key aspects of genetic management include:

• Molecular Confirmation: Identifying the specific GNAS mutation to confirm a diagnosis of Progressive Osseous Heteroplasia.


• Parental Testing: Assessing parents to determine if the mutation is inherited or a de novo event.


• Reproductive Options: Families may explore prenatal diagnosis or preimplantation genetic testing (PGT) if a familial mutation is identified.

How common are de novo mutations in this condition?

In many documented cases of Progressive Osseous Heteroplasia, the mutation occurs spontaneously. While the exact percentage of de novo versus inherited cases is difficult to quantify precisely due to the rarity of the disease, clinical literature suggests that spontaneous mutations are a significant contributor to the prevalence of Progressive Osseous Heteroplasia. If you are part of the small community of individuals affected by Progressive Osseous Heteroplasia, including the one member currently on DiseaseMaps.org, understanding your specific genetic status is the first step in personalized management.

Next steps

• Consult with a board-certified clinical geneticist to discuss diagnostic molecular testing.


• Reach out to the DiseaseMaps.org community to connect with others navigating rare bone disorders.


• Maintain regular follow-ups with specialists, such as pediatric endocrinologists or orthopedists, to monitor the progression of ossification.

Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment; always seek the advice of your physician with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Progressive Osseous Heteroplasia.


• Online Mendelian Inheritance in Man (OMIM): #166350 Progressive Osseous Heteroplasia.


• Orphanet: ORPHA68393 - Progressive Osseous Heteroplasia.